Article Topic
The FDA speaks up about AFPs and drug importation
Is personal drug importation legal in the context of alternative funding programs? The FDA says no.
Are self-funded health plans allowed to import medicine because of “Section 804” or “Florida’s importation plan”? Also, no.
[...]Case overview: USA v Adam Brosius, Patrick Boyd and Charles Boyd (2024 – 2026)
Adam Brosius and Charles and Patrick Boyd were proprietors of Safe Chain Solutions, a Maryland drug wholesaler that sold distributed misbranded and adulterated drugs and trafficked medicine products with false documentation. The men have been sentenced to a combined 46 years in prison.
[...]Photo gallery, USA v Boyd exhibits
Photo gallery, USA v Boyd exhibits Two bottles of Biktarvy, lot CCZCBA. (Exhibit 30) A Biktarvy bottle filled with the antipsychotic Seroquel. (Exhibit 192) A Biktarvy bottle filled with the antipsychotic Seroquel. (Exhibit 192) A Biktarvy bottle filled with the antipsychotic Seroquel. (Exhibit 192) Seroquel found in a Biktarvy bottle. (Exhibit 192) Patient’s photo of…
[...]Using pharmacy-to-pharmacy marketplaces? Read this Suspicious Sales Surveillance Report
Online pharmacy-to-pharmacy marketplaces help with inventory management, but they also require vigilance because they carry a higher risk of being exploited by criminals selling black market medicines.
[...]Counterfeit drug crimes typically earn light sentences. How did Safe Chain’s co-owners, the Boyd brothers, end up with 18 and 20 years?
Wire fraud charges drove much higher penalties than the shipping of unsafe medicine into the supply chain, and the Boyds’ sentences were based on the government proving high-dollar, deliberate fraud.
[...]Plea Agreement, USA v Sanjay Kumar
United States District Court Southern District of Texas, Houston Division USA v Sanjay Kumar Plea agreement Filed October 2025 Read the document.
[...]March Drug Importation Madness
For a pretty dead policy idea, bulk drug importation has had a lot of news lately. Get the update!
[...]PSM asks federal agencies to review Hims & Hers’ 2026 Super Bowl ad
On March 10, PSM sent letters to the FDA, FTC, and the Department of Justice asking them to take immediate action to address the ad’s false and misleading promotion of its compounded programs and diagnostic tests.
[...]Cases to watch
PSM watches court cases that have an impact on drug supply chain safety. Click through to these cases to follow along with us.
[...]Case overview: Novartis AG and Genentech v SHARx and Campbell Heights Pharmacy (2026 — ) – ongoing
Novartis and Genentech have filed a Lanham Act complaint against an alternative funding program and a Canadian pharmacy allegedly supplying Canadian Xolair to Michigan patients.
[...]